BFA
BlackRock Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $502M | Buy |
6,818,014
+555,138
| +9% | +$40.9M | 0.09% | 202 |
|
|
2016
Q3 | $546M | Buy |
6,262,876
+234,950
| +4% | +$20.5M | 0.11% | 163 |
|
|
2016
Q2 | $519M | Buy |
6,027,926
+175,498
| +3% | +$15.1M | 0.11% | 160 |
|
|
2016
Q1 | $465M | Buy |
5,852,428
+416,837
| +8% | +$33.1M | 0.11% | 176 |
|
|
2015
Q4 | $684M | Sell |
5,435,591
-276,878
| -5% | -$34.8M | 0.16% | 99 |
|
|
2015
Q3 | $595M | Buy |
5,712,469
+158,758
| +3% | +$16.5M | 0.15% | 96 |
|
|
2015
Q2 | $686M | Sell |
5,553,711
-750,894
| -12% | -$92.7M | 0.16% | 86 |
|
|
2015
Q1 | $744M | Buy |
6,304,605
+515,366
| +9% | +$60.8M | 0.18% | 85 |
|
|
2014
Q4 | $688M | Buy |
5,789,239
+180,714
| +3% | +$21.5M | 0.17% | 94 |
|
|
2014
Q3 | $630M | Sell |
5,608,525
-182,528
| -3% | -$20.5M | 0.18% | 80 |
|
|
2014
Q2 | $548M | Sell |
5,791,053
-94,471
| -2% | -$8.94M | 0.15% | 103 |
|
|
2014
Q1 | $416M | Buy |
5,885,524
+430,553
| +8% | +$30.4M | 0.12% | 134 |
|
|
2013
Q4 | $405M | Buy |
5,454,971
+665,401
| +14% | +$49.4M | 0.12% | 128 |
|
|
2013
Q3 | $363M | Sell |
4,789,570
-2,163,705
| -31% | -$164M | 0.12% | 130 |
|
|
2013
Q2 | $557M | Buy |
+6,953,275
| New | +$557M | 0.2% | 72 |
|